Guangyi P. Liu
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Weight-adjusted waist index and risk of cardiovascular and all-cause mortality in chronic kidney disease: NHANES 2005-2018 analysis of 5,381 adults.
Journal: Renal failure
Published: August 27, 2026
Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism.
Journal: Cell metabolism
Published: July 20, 2026
Age at disease onset and risk of chronic kidney disease in patients with heterozygous disease-causing variants in COL4A3 and COL4A4.
Journal: Clinical kidney journal
Published: May 21, 2025
Association between relative fat mass (RFM) and chronic kidney disease (CKD): data from NHANES 2005-2018.
Journal: Scientific reports
Published: February 16, 2025
CUL4B protects kidneys from acute injury by restraining p53/PAI-1 signaling.
Journal: Cell death & disease
Published: May 11, 2024
Case report: Effective treatment of rituximab-resistant minimal change disease with obinutuzumab in an adult.
Journal: Frontiers in immunology
Published: March 26, 2024
Identification of two novel SALL1 mutations in chinese families with townes-brocks syndrome and literature review.
Journal: Orphanet journal of rare diseases
Published: May 16, 2023
Depletion of CUL4B in macrophages ameliorates diabetic kidney disease via miR-194-5p/ITGA9 axis.
Journal: Cell reports
Published: September 01, 2022
Generation of two induced pluripotent stem cell lines from patients with X-linked Alport syndrome.
Journal: Stem cell research
Published: March 12, 2021
Generation and characterization of an integration-free iPSC line SDUBMSi006-A from a patient with Alport syndrome caused by COL4A3 gene mutations.
Journal: Stem cell research
Published: November 19, 2020
Compound Mutations of the COL4A3 including a Novel Allele Identified in a Patient with Alport Syndrome.
Journal: BioMed research international
Published: June 11, 2020
Wogonin Induces Apoptosis and Reverses Sunitinib Resistance of Renal Cell Carcinoma Cells via Inhibiting CDK4-RB Pathway.
Journal: Frontiers in pharmacology
Published: April 08, 2020
Last Updated: 09/26/2026